2234
I. Westmoreland et al. / Journal of Organometallic Chemistry 691 (2006) 2228–2236
m, CHMe2), 1.37 (9H, s, tBu) 1.28 (9H, s, tBu), 0.96 (3H, s,
Me), 0.88 (3H, s, Me) ppm.
4JHH = 3 Hz, Ar–H), 4.15 (1H, m, CH2), 3.95 (2H, m,
CH and CH2), 3.60 (m, THF), 1.85 (1H, m, CHMe2),
1.74 (9H, s, Bu), 1.60 (m, THF), 1.43 (9H, s, Bu), 0.83
(3H, s, CH3), 0.73 (3H, s, CH3).
t
t
13C{1H} NMR dC (100.6 MHz, 298 K, CDCl3) 166.0,
157.0, 139.9, 136.4, 127.9, 122.1 (Ar), 109.8, (C@N), 71.7
(CH), 69.6 (CH2), 35.2, 34.3, (CMe3), 33.1, (CHMe2),
31.5, 29.5 (C Me3), 18.9, 18.7 (CHMe2) ppm.
4.3.3. (S)-KL3 Æ (THF)0.80
MS (EI+) m/z: 317 (100%, M+), 302 (85%, M+ꢀCH3),
Yield 210 mg, 92%. 1H NMR (400 MHz, 298 K, d5-pyr-
t
4
260 (45%, M+ꢀ Bu).
idine): dH 8.14 (1H, d, JHH = 3 Hz, Ar–H), 7.66 (1H, d,
IR (Golden gate) m cmꢀ1: 2959, 2870, 1633, 1595, 1468,
1437, 1391, 1362, 1288, 1274, 1253, 1215, 1188, 1103, 1044,
1030, 980, 822, 783, 772, 765, 728.
4JHH = 3 Hz, Ar–H), 7.32 (2H, m, Ar–H), 7.17 (3H, m,
Ar–H), 5.35 (1H, m, CH2), 4.33 (1H, m, CH), 3.91 (1H,
t
m, CH2), 3.60 (m, THF), 1.79 (9H, s, Bu), 1.60 (m,
t
EA Calc. for C20H31NO2: C, 75.67; H, 9.84; N, 4.41.
Found: C, 75.66; H, 9.87; N, 4.18%.
THF), 1.49 (9H, s, Bu).
4.4. Zirconium benzyls
4.2.3. (S)-HL3
4.4.1. L12Zr CH2Ph
From (S)-(+)-2-phenylglycinol (1.10 g, 8.0 mmol). Yield
2
1
2.1 g, 75%. H NMR dH (400 MHz, 298 K, CDCl3) 12.48
A solution of Zr(CH2Ph)4 (153 mg, 0.336 mmol) in tol-
uene (10 ml) was cooled to ꢀ78 ꢁC with stirring. To this
was added a solution of (S)-HL1 (222 mg, 0.670 mmol) in
toluene (10 ml). The resulting yellow solution was stirred
at this temperature for 1 h in the absence of light. The cold
bath was then removed and the reaction mixture was
allowed to warm to ambient temperature. Stirring was con-
tinued for a further 15 h. After this time the solvent was
removed in vacuo, and an orange residue was obtained.
The residue was re-dissolved in pentane and filtered. The
filtrate was reduced in volume to ca. 5 ml, and cooled to
ꢀ30 ꢁC. After cooling for 12 h at this temperature, the
product was obtained as fine orange crystals. Yield
331 mg, 92%.
4
(1H, bs, OH), 7.56 (1H, d, JHH = 2 Hz, Ar–H), 7.42
4
(1H, d, JHH = 2 Hz, Ar–H), 7.31 (2H, m, Ar–H), 7.26
2
3
(3H, m, Ar–H), 5.40 (1H, dd, JHH = 8 Hz, JHH = 2 Hz,
2
3
CH2), 4.72 (1H, dd, JHH = 8 Hz, JHH = 2 Hz, CH),
4.18 (1H, t, JHH = 8 Hz, CH2), 1.40 (9H, s, Bu) 1.28
3
t
t
(9H, s, Bu) ppm.
13C{1H} NMR dC (100.6 MHz, 298 K, CDCl3) 167.2,
157.1, 141.8, 140.1, 136.6, 128.8, 128.3, 127.8, 126.6,
122.3 (Ar), 109.6 (C@N), 73.8 (CH2), 69.0 (CH), 35.2,
34.3 (CMe3), 31.5, 29.5 (C Me3) ppm.
MS (EI+) m/z: 351 (100%, M+), 336 (85%, M+ꢀCH3),
t
294 (30%, M+ꢀ Bu).
IR (Golden gate) m cmꢀ1: 2958, 1632, 1439, 1390, 1367,
1344, 1276, 1252, 1187, 1141, 1103, 980, 894, 820, 786, 754,
717.
1H NMR dH (400 MHz, 298 K, CD2Cl2) 7.54 (2H, d,
4JHH = 2 Hz, Ar–H), 7.49 (2H, d, JHH = 2 Hz, Ar–H),
4
6.66 (4H, t, 3JHH = 7 Hz, Ar–H), 6.51 (4H, d, 3JHH = 7 Hz,
EA Calc. for C23H29NO2: C, 78.59; H, 8.32; N, 3.99.
Found: C, 78.50; H, 8.46; N, 3.95%.
3
Ar–H), 6.40 (2H, d, JHH = 7 Hz, Ar–H), 4.09 (2H, dd,
3
2JHH = 8 Hz, JHH = 2 Hz, oxazoline CH2), 4.00 (2H, dd,
3
4.3. Potassium salts of proligands
2JHH = 8 Hz, JHH = 2 Hz, oxazoline CH), 3.28 (2H, t,
3JHH = 8 Hz, oxazoline CH2), 2.25 (2H, d, JHH = 10 Hz,
2
2
THF (15 ml) was added to a Schlenk vessel charged with
proligand (0.55 mmol) and potassium hydride (44 mg,
1.10 mmol). The resulting yellow suspension was stirred
for 15 h under reduced pressure. After this time the stirring
was ceased and unreacted KH was allowed to settle. The
solution was filtered via cannula, and the yellow filtrate
was concentrated in vacuo to yield a yellow microcrystalline
benzyl CH2), 2.20 (2H, d, JHH = 10 Hz, benzyl CH2),
1.61 (18H, s, tBu) 1.26 (18H, s, tBu), 0.50 (18H, s,
tBu) ppm.
13C{1H} NMR dC (100.6 MHz, 298 K, CD2Cl2) 172.8,
160.7, 151.8, 141.1, 138.0, 130.2, 127.8, 125.3, 124.5,
119.3 (Ar), 116.7 (C@N), 73.5, (CH), 69.3 (oxazoline
CH2), 67.9 (benzyl CH2), 35.8, 35.4, 34.7 (CMe3), 31.6,
30.7, 25.5 (C Me3) ppm.
1
solid. Analysis by H NMR spectroscopy in d5-pyridine
enabled the composition of the product to be established.
MS (CI+) m/z: 934 (20%, M+), 843 (100%,
M+ꢀCH2Ph).
4.3.1. (S)-KL1 Æ (THF)0.75
IR (Nujol) m cmꢀ1: 1594, 1556, 1461, 1377, 1301, 1259,
1222, 1206.
Yield 241 mg, 93%. 1H NMR (400 MHz, 298 K, d5-pyr-
4
idine): dH 8.04 (1H, d, JHH = 3 Hz, Ar–H), 7.61 (1H, d,
EA Calc. for C56H78N2O4Zr: C, 71.98; H, 8.41; N, 3.00.
Found: C, 71.68; H, 8.36; N, 2.95%.
4JHH = 3 Hz, Ar–H), 4.07 (3H, m, CH and CH2), 3.67
t
(m, THF), 1.74 (9H, s, Bu), 1.63 (m, THF), 1.45 (9H, s,
t
tBu), 0.88 (9H, s, Bu).
4.4.2. L22Zr CH2Ph
2
Yield 205 mg, 79%. 1H NMR dH (400 MHz, 298 K,
4.3.2. (S)-KL2 Æ (THF)1.25
C6D6) 7.81 (2H, d, JHH = 2 Hz, Ar–H), 7.69 (2H, d,
4
Yield 260 mg, 93%. 1H NMR (400 MHz, 298 K, d5-pyr-
4JHH = 2 Hz, Ar–H), 6.97 (4H, d, JHH = 7 Hz, Ar–H),
3
4
idine): dH 8.07 (1H, d, JHH = 3 Hz, Ar–H), 7.60 (1H, d,
6.88 (4H, t, 3JHH = 8 Hz, Ar–H), 6.60 (2H, t, 3JHH = 7 Hz,